Stay ahead of industry shifts with insights from the AMCP Foundation’s Emerging Trends Initiative. Published in JMCP, this report explores key developments in technology, therapeutics, payment models, pharmacy operations, and policy. Learn how these trends impact managed care pharmacy professionals and what they mean for you and your business.

Academy of Managed Care Pharmacy (AMCP) issued the following statement from AMCP CEO Susan A. Cantrell, MHL, RPh, CAE, about President Trump’s potential executive order to cut thousands of jobs at the Department of Health and Human Services:

Read the Journal of Managed Care + Specialty Pharmacy (JMCP) February 2025 Issue

The Academy of Managed Care Pharmacy (AMCP) thanks the Food and Drug Administration (FDA) for the opportunity to provide comments in response to the “Expedited Program for Serious Conditions — Accelerated Approval of Drugs and Biologics” (Draft Guidance), issued on December 5, 2024.

The Academy of Managed Care Pharmacy (AMCP) issued the following statement from AMCP CEO Susan A. Cantrell, MHL, RPh, CAE, regarding President Trump’s new and proposed tariffs on U.S. imports from Canada, Mexico, and China: “Although President Trump’s new and proposed tariffs aim to level the playing field between American industries and our foreign competitors, we are concerned about the unintended, adverse consequences they may have on the cost of medicines in the U.S.